Synthetic Cannabinoid Reports and Animal Experiments Answer Different Toxicity Questions

Reports of reactions to synthetic cannabinoids and controlled animal experiments provide different kinds of toxicity evidence. A 2017 review of “Spice” combined those literatures while emphasizing methodological and exposure uncertainties. Their findings should not be merged into a single marijuana risk estimate.

A reported human event can raise a safety signal

An account of symptoms after a suspected product exposure can identify a concerning event. By itself, it may not establish the precise compound, dose or contribution of other substances. Those are limits of causal interpretation, not grounds for dismissing the observation. The review's inclusion of anecdotal material should remain visible when its conclusions are summarized.

Controlled assays answer narrower experimental questions

The review examined behavioral assays of abuse liability, tolerance, dependence, withdrawal and potential toxicity, often using THC as a comparator. A controlled exposure can clarify what a specified compound does under particular conditions. An animal assay still cannot reproduce every circumstance of an unidentified human product exposure or directly measure a person's subjective experience.

Route and compound identity matter to comparison

The authors discussed administration methods and other logistical issues as important methodological considerations. A result for one synthetic cannabimimetic cannot establish identical effects for all substances sold as Spice. Likewise, using THC as a comparator does not make the synthetic compound equivalent to plant cannabis. Each conclusion needs to retain its compound, route and endpoint.

Interpreting the evidence

The review's description of an early and limited literature is historically bounded to its publication period. Its useful lesson is to combine safety signals and experimental findings without erasing their different strengths. It does not provide a current numerical risk ranking for all synthetic cannabinoids or cannabis products.

Related reading: differences between plant and synthetic cannabinoid evidence.

Research reference

Järbe TUC; Raghav JG (2017). Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man. Current topics in behavioral neurosciences. doi:10.1007/7854_2016_16. Evidence basis: review abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Why Blocking Endocannabinoid Breakdown May Affect More Than Cannabinoid Signaling

Inhibiting endocannabinoid breakdown is not necessarily equivalent to selectively activating a cannabinoid receptor. A 2014 pain-research review identified tolerance and pain-promoting prostamides as potential limits on the benefits of cannabinoid-hydrolyzing enzyme inhibitors. An enzyme intervention can change a signaling network Enzyme inhibition alters the handling of signaling molecules rather than…

Spread the love

Read Article: Why Blocking Endocannabinoid Breakdown May Affect More Than Cannabinoid Signaling

Synthetic Cannabinoid Reports and Animal Experiments Answer Different Toxicity Questions

Reports of reactions to synthetic cannabinoids and controlled animal experiments provide different kinds of toxicity evidence. A 2017 review of “Spice” combined those literatures while emphasizing methodological and exposure uncertainties. Their findings should not be merged into a single marijuana risk estimate. A reported human event can raise a safety…

Spread the love

Read Article: Synthetic Cannabinoid Reports and Animal Experiments Answer Different Toxicity Questions

Astroglial CB1 Findings After Electroacupuncture Are Not Evidence That THC Treats Stroke

A mouse study linked electroacupuncture-induced protection against cerebral ischemic injury to astroglial CB1 receptors. The intervention was electroacupuncture pretreatment, not THC. Receptor involvement therefore cannot be relabeled as evidence that marijuana treats stroke. The investigators examined a specific injury model The 2021 study used a middle cerebral artery occlusion model…

Spread the love

Read Article: Astroglial CB1 Findings After Electroacupuncture Are Not Evidence That THC Treats Stroke

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us